Drug Pricing’s New Frontier – The Inflation Reduction Act

Jillanne Schulte Wall, JD, (she/her) is the senior director of health & regulatory policy for the American Society of Health-System Pharmacists (ASHP) in Bethesda, MD. She serves as ASHP’s primary liaison to federal regulatory agencies and, in conjunction with other members of the Government Relations team, develops and communicates of ASHP’s positions on federal and state laws, regulations, and guidance related to the profession of pharmacy.  Additionally, Jillanne works closely with stakeholders in pharmacy, medicine, manufacturing, and patient advocacy on legislative and regulatory issues of importance to ASHP members. 

Tom Kraus, JD, MHS serves as the vice president of government relations for ASHP. Kraus previously served as the deputy staff director of health on the U.S. Senate Committee on Health, Education, Labor and Pensions under Senators Edward Kennedy and Tom Harkin, where he was instrumental in the passage of key legislation, including Food and Drug Administration (FDA) drug and food safety reforms and user fee legislation, the American Recovery and Reinvestment Act, and the Affordable Care Act. Following his time on Capitol Hill, he joined the FDA, where he served as Chief of Staff and Associate FDA Commissioner for Legislation.